GEA
BSX icon

Glen Eagle Advisors’s Boston Scientific BSX Stock Holding History

Glen Eagle Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
24,524
+2,907
+13% +$158K 0.13% 111
2026
Q1 		$1.36M Buy
21,617
+8,380
+63% +$670K 0.19% 90
2025
Q4 		$1.26M Buy
13,237
+4,664
+54% +$457K 0.17% 97
2025
Q3 		$837K Buy
8,573
+8,016
+1,439% +$830K 0.12% 119
2025
Q2 		$59.8K Hold
557
– – 0.01% 392
2025
Q1 		$56.2K Hold
557
– – 0.01% 395
2024
Q4 		$49.8K Sell
557
-290
-34% -$25.5K 0.01% 410
2024
Q3 		$71K Hold
847
– – 0.01% 364
2024
Q2 		$65.2K Buy
847
+290
+52% +$21.2K 0.01% 364
2024
Q1 		$38.1K Hold
557
– – 0.01% 454
2023
Q4 		$32.2K Buy
557
+90
+19% +$4.8K 0.01% 458
2023
Q3 		$24.7K Hold
467
– – 0.01% 488
2023
Q2 		$25.3K Hold
467
– – 0.01% 484
2023
Q1 		$23.4K Buy
467
+167
+56% +$7.87K 0.01% 488
2022
Q4 		$13.9K Hold
300
– – ﹤0.01% 550
2022
Q3 		$11.6K Hold
300
– – ﹤0.01% 568
2022
Q2 		$11.2K Hold
300
– – ﹤0.01% 597
2022
Q1 		$13.3K Hold
300
– – ﹤0.01% 574
2021
Q4 		$12.7K Sell
300
-5
-2% -$210 ﹤0.01% 577
2021
Q3 		$13.3K Hold
305
– – ﹤0.01% 642
2021
Q2 		$13K Hold
305
– – ﹤0.01% 642
2021
Q1 		$11.8K Buy
305
+5
+2% +$189 ﹤0.01% 635
2020
Q4 		$10.8K Hold
300
– – ﹤0.01% 621
2020
Q3 		$11.5K Sell
300
-93
-24% -$3.58K 0.01% 572
2020
Q2 		$13.8K Buy
393
+93
+31% +$3.35K 0.01% 506
2020
Q1 		$9.79K Hold
300
– – 0.01% 514
2019
Q4 		$13.6K Hold
300
– – 0.01% 522
2019
Q3 		$12.2K Sell
300
-27
-8% -$1.14K 0.01% 477
2019
Q2 		$14.1K Hold
327
– – 0.01% 451
2019
Q1 		$12.6K Buy
327
+27
+9% +$1.03K 0.01% 447
2018
Q4 		$10.6K Buy
+300
New +$10.9K 0.01% 451

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Glen Eagle Advisors's BSX Position: Q2 2026 in Review

Glen Eagle Advisors increased its Boston Scientific (BSX) stake by 13% in Q2 2026, buying an estimated $158K and bringing the position to 24,524 shares worth $1.05M. The position accounts for 0.13% of the portfolio, ranked #111.

Glen Eagle Advisors first reported a position in BSX in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.36M in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Glen Eagle Advisors held 24,524 shares of Boston Scientific worth $1.05M as of Q2 2026.
  • Glen Eagle Advisors bought 2,907 Boston Scientific shares in Q2 2026, an estimated $158K.
  • Boston Scientific made up 0.13% of Glen Eagle Advisors's portfolio in Q2 2026, its #111 holding.
  • Glen Eagle Advisors first reported a position in Boston Scientific in Q4 2018 and has held it in 31 quarters since.
  • Glen Eagle Advisors's Boston Scientific position peaked at $1.36M in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.